DNLI

DENALI THERAPEUTICS INC

DNLI·24823R105·US·Common Stock·Healthcare - Biotechnology-13D/G

DNLI (DENALI THERAPEUTICS INC) is held by 149 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($360.8M), BAILLIE GIFFORD & CO ($307.6M), STATE STREET CORP ($181.3M). Net institutional sentiment: Mixed.

149
Holders
(9 Elite)
$3.2B
Total Value
66% (143)
Consensus
94 buying - 49 selling
13F: Insider & Congress: Updated regularly
DNLI

Smart Money Verdict

View all
Loading verdict
Held by 149 funds
9 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Sep 9, 2026 · Activists Aug 4, 2026 · Congress none

InsiderCSChin Peter ScottSell $37KSep 4, 2026
InsiderTNThornberry NancySell $247KSep 2, 2026
InsiderTNThornberry NancySell $15KSep 2, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
14M(+7.6%)$360.8M0.0%-34.41%
33
Decreased
12M(-0.9%)$307.6M0.3%-50.45%
0
Increased
7M(+12.4%)$181.3M0.0%-23.47%
34
Unchanged
7M$180.4M0.5%-21.35%
0
Increased
6.5M(+5.8%)$166.6M0.0%-9.81%
32
Increased
6.3M(+2.1%)$161.4M0.0%-8.92%
31
Decreased
4.5M(-0.9%)$116.7M0.0%-35.43%
0
Decreased
4.2M(-5.7%)$106.9M0.0%+0.85%
0
Increased
4M(+6.6%)$102.2M0.0%-34.42%
32
Increased
3.9M(+22.2%)$100.4M0.2%+10.61%
43
Increased
3.7M(+0.1%)$96M0.5%-22.24%
36
Decreased
3.2M(-28.7%)$81.3M0.0%-14.90%
0
Increased
3.1M(+27.3%)$80.7M0.0%-23.87%
37
Increased
3.1M(+21.4%)$80.3M0.0%-1.40%
36
Increased
2.9M(+6.3%)$73.6M0.0%-20.35%
32
Increased
2.8M(+9.1%)$71.9M0.1%-0.91%
32
Increased
2.6M(+2.0%)$66M0.0%-24.62%
30
Decreased
2.4M(-0.9%)$62.1M0.0%+5.95%
0
Increased
3M(+3.1%)$57.3M0.0%-24.74%
30
Increased
2.2M(+1828.2%)$56.8M0.1%-27.36%
47

Showing 1-20 of 155

1 / 8
DNLIDNLIDENALI THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used